Latest updates for Glp-1 Weight Loss

Fresh curated links around GLP-1 Weight Loss are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • GLP-1 and dual GLP-1 / GIP drugs help lose body fat while preserving lean mass
  • Dietitian explains how to maintain weight loss after taking GLP-1 medication
  • GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

news-medical.net /1 month ago

GLP-1 and dual GLP-1 / GIP drugs help lose body fat while preserving lean mass

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agoni...

Read source
spectrumlocalnews.com /1 week ago

Dietitian explains how to maintain weight loss after taking GLP-1 medication

GLP-1s can curb an appetite. A dietician explains how to change eating behavior to maintain weight loss.

Read source
scitechdaily.com /2 weeks ago

GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...

Read source
healio.com /3 weeks ago

GLP-1s sustain weight loss in IBD, obesity without worse symptoms

CHICAGO — Patients with obesity and inflammatory bowel disease showed improved bowel function while receiving GLP-1 receptor agonists and lifestyle counseling, in contrast to the g...

Read source
sciencedaily.com /1 week ago

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...

Read source
nytimes.com /1 week ago

Experimental Drug Yields Dramatic Weight Loss

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

Read source
localnews8.com /1 month ago

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway

By Meg Tirrell, CNN (CNN) — For the majority of people who start using GLP-1 medicines with the hope of losing weight, the drugs can feel almost miraculous: Cravings are quieted. E...

Read source
localnews8.com /1 month ago

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway

By Meg Tirrell, CNN (CNN) — For the majority of people who start using GLP-1 medicines with the hope of losing weight, the drugs can feel almost miraculous: Cravings are quieted. E...

Read source
localnews8.com /1 month ago

Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway

By Meg Tirrell, CNN (CNN) — For the majority of people who start using GLP-1 medicines with the hope of losing weight, the drugs can feel almost miraculous: Cravings are quieted. E...

Read source
biopharmadive.com /2 weeks ago

Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss

A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down ove...

Read source
lifespan.io /2 weeks ago

GLP-1 Drugs’ Muscle Effects Similar to Ordinary Weight Loss

A new study suggests that GLP-1 receptor agonists do not affect muscle mass any more than weight loss caused by caloric restriction, and this appears to be true for strength as wel...

Read source
westlakedermatology.com /2 weeks ago

18 Common GLP-1 Weight Loss Mistakes to Avoid

GLP-1 weight loss medications such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound™ have transformed the way we approach weight loss and metabolic health. These treatments mimic...

Read source
news-medical.net /4 weeks ago

GLP-1 drugs reduce risk of major adverse cardiovascular events

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.

Read source
scitechdaily.com /4 weeks ago

Popular Weight-Loss Drugs Found To Cut Heart Attack and Stroke Risk

A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or blood sugar. New research suggests that GLP-1 weight loss drugs may provide lasting p...

Read source
huffpost.com /1 week ago

GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss

A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

Read source
drugs.com /1 month ago

New Weight Loss Research Questions Need for GLP-1 Drugs

FRIDAY, April 17, 2026 — A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achie...

Read source
arthroplastyjournal.org /4 weeks ago

GLP-1 Receptor Agonist Weight Loss Therapy and Arthroplasty: Are Women at Greater Risk for Complications?

The GLP-1 receptor agonists have profoundly revolutionized metabolic therapy. These agents have rapidly become central to obesity management, producing substantial effects on weigh...

Read source
refractor.io /2 days ago

Brain-cell breakthrough supercharges GLP-1 weight loss and prevents plateaus

Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users pu...

Read source
washingtontimes.com /1 month ago

Weight-loss drug competition heats up with new GLP-1 pill

The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.

Read source
washingtontimes.com /1 month ago

Weight-loss drug competition heats up with new GLP-1 pill

The U.S. Food and Drug Administration has approved a new GLP-1 for weight loss, adding a new once-daily pill to the pharmaceutical competition over the popular drugs.

Read source
news-medical.net /2 weeks ago

GLP-1 weight loss medications linked to significant drop in asthma flares

New research presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new GLP-1 class of obesity drugs in people with asthma is as...

Read source
neurosciencenews.com /2 weeks ago

GLP-1 Drugs Dramatically Reduce “Food Noise” in Weight Loss

GLP-1 medications effectively "turn down the volume" on intrusive food thoughts. In a study of 417 adults, those combining medication with behavioral therapy saw a significantly gr...

Read source
scientificamerican.com /1 month ago

How Eli Lilly’s new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks

Read source
neurosciencenews.com /1 week ago

Study Aims to Break GLP-1 Weight-Loss Plateaus

The weight-loss effects of semaglutide depend on boosting a signaling molecule called cAMP within appetite-regulating neurons in the area postrema.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Glp-1 Weight Loss

feeds.feedburner.com

Recent coverage from public sources
Public source

rss.nytimes.com

Recent coverage from public sources
Public source

rss.sciam.com

Recent coverage from public sources
Public source

localnews8.com

Recent coverage from public sources
Public source

neurosciencenews.com

Recent coverage from public sources
Public source

newatlas.com

Recent coverage from public sources
Public source